Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLansoprazole and Mounjaro can generally be taken together, but timing matters. Mounjaro slows gastric emptying, which may affect how quickly lansoprazole is absorbed — and because lansoprazole is designed to be taken on an empty stomach, the overlap is worth understanding before you start treatment. Lansoprazole is a proton pump inhibitor (PPI) that reduces stomach acid; Mounjaro is tirzepatide, a once-weekly injection licensed in the UK for weight management. Neither drug is formally contraindicated with the other, but the decision about whether your current combination is right for you belongs with your prescriber, not a search engine. Mounjaro is a prescription-only medicine, and a clinician assesses your full medication list as part of any consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you're already taking lansoprazole and you've just been offered Mounjaro, the question running through your head is probably a practical one: do I need to change anything? That's a fair concern, and the answer is nuanced rather than alarming.
Mounjaro (tirzepatide) slows the rate at which the stomach empties its contents into the small intestine. This effect (called delayed gastric emptying) is part of how it reduces appetite and calorie intake. It also means that oral medicines taken alongside it may spend longer in the stomach before reaching the small intestine, where most absorption happens.
Lansoprazole is a proton pump inhibitor taken to reduce stomach acid. Standard guidance is to swallow it first thing in the morning, thirty minutes before food, so it can be absorbed before the acid-suppressing mechanism kicks in. If gastric emptying is already slower than usual, the practical impact on lansoprazole's absorption profile is theoretically possible, though clinical evidence specifically quantifying this interaction is limited. The BNF entry for tirzepatide flags that GLP-1 and dual-agonist medicines may affect the absorption of concomitant oral medicines generally, and that this should be considered when clinically relevant. That note is not a ban on combining them; it is a prompt to be thoughtful about timing and monitoring.
For most people, continuing lansoprazole at its usual dose and timing remains reasonable. The key is ensuring your prescriber knows you take it.
Here is something the anxiety around this question sometimes obscures: for a meaningful proportion of people starting Mounjaro, a PPI like lansoprazole is not just tolerated but actively useful. Gastrointestinal side effects, particularly nausea, indigestion, reflux and heartburn, are among the most commonly reported effects of tirzepatide, particularly in the early weeks or after a dose increase.
The NHS patient information page for tirzepatide lists indigestion and reflux among the common side effects. Prescribers managing these symptoms sometimes recommend continuing an existing PPI or initiating one temporarily to smooth the adjustment period.
So the interaction question can run in both directions. If you're already on lansoprazole for a pre-existing condition such as reflux or a peptic ulcer, there is generally no reason to stop it when starting Mounjaro. If you develop significant upper GI symptoms on Mounjaro and you're not already on a PPI, that is a conversation worth having with your prescriber or pharmacist rather than something to manage alone. Dose titration on Mounjaro (starting at 2.5 mg and stepping up gradually) is partly designed to give the body time to adjust to these effects, so the side-effect window is usually finite.
The interaction between omeprazole and Mounjaro follows a broadly similar pattern, if you've seen that query too.
Assuming your prescriber is happy with the combination, a few practical habits make the most of both medicines.
Take lansoprazole first, before anything else, with a small glass of water, and leave the recommended thirty-minute gap before eating or taking other oral medicines. Your Mounjaro injection is subcutaneous, so it bypasses the stomach entirely and is not affected by the empty-stomach rule. Inject Mounjaro on the same day each week (abdomen, thigh or upper arm, rotating sites) regardless of when you take lansoprazole that morning. The two do not need to be physically separated in time because the injection does not compete for gastrointestinal absorption.
If you are on lansoprazole to treat a condition related to Helicobacter pylori, your GP or gastroenterologist may have prescribed metronidazole alongside it as part of an eradication course, mention that to your Mounjaro prescriber too, as antibiotic courses are a temporary complexity worth flagging.
Missed doses, changes to your lansoprazole dose, or new gastrointestinal symptoms that feel different from ordinary reflux (particularly severe, persistent pain that spreads to the back) should prompt contact with your prescriber promptly. The MHRA's January 2026 Drug Safety Update highlighted acute pancreatitis as a rare but serious risk with GLP-1 medicines; stomach symptoms that do not fit the usual reflux pattern deserve clinical assessment rather than self-management.
If you are weighing up your options for starting tirzepatide, our page on weight-loss treatments at nume sets out how the consultation process works and what is included. You can also explore the broader picture of what Mounjaro involves before deciding whether it is right for you.
Every clinical review at nume (sorry, at a registered pharmacy) should include a full medicines reconciliation. At nume, a GPhC-registered Independent Prescriber personally reviews your consultation, including your current medication list, before any prescription is issued. This is not a box-ticking exercise; a real clinician reads your answers the same day.
For the lansoprazole question specifically, they will want to know the dose you are on, what it is treating, and how long you have been taking it. That context shapes whether they suggest any timing adjustments, whether to monitor more closely in the early weeks of Mounjaro, or whether your GP should be kept in the loop about the new treatment, our clinical team notifies your GP in line with GPhC guidance as standard practice.
If you have seen queries about pantoprazole and Mounjaro or esomeprazole and Mounjaro in your research, the broad principles are the same across the PPI class, though individual prescribing decisions are always specific to you. If you are based in the South West and wondering about local access, our Mounjaro Exeter page explains how the service works in that area. The weight-loss treatments overview is a useful starting point if you are still working out where to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.